Companies › MESO

MESOBLAST LTD (MESO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001345099 · EDGAR filings · Updated 2026-07-21

MESOBLAST LTD (MESO) has reported institutional ownership of 0.3%, with 68 institutional managers holding positions valued at $50.5M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-21 — Foreign issuer report (6-K) filed
• 2026-07-15 — Foreign issuer report (6-K) filed
• 2026-07-14 — Foreign issuer report (6-K) filed
• 2026-07-10 — Foreign issuer report (6-K) filed
• 2026-07-09 — Insider transaction reported (Form 4)
• 2026-07-01 — Foreign issuer report (6-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MESOBLAST LTD has 68 institutional holders and institutional ownership of 0.3%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 5 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

MDXHEALTH SA (MDXH) · Inovio Pharmaceuticals Inc (INO) · BIODESIX INC (BDSX) · SPRUCE BIOSCIENCES INC COM NEW (SPRB) · Spero Therapeutics Inc (SPRO) · CARLSMED INC (CARL)